Technical analysis of Soligenix, Inc. (SNGX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Soligenix, Inc., a biopharmaceutical firm in its advanced development stages, concentrates on bringing innovative products to market within the United States, specifically targeting rare illnesses. The company's operations are divided into two main divisions: Specialized BioTherapeutics and Public Health Solutions.
Price Performance
| 1 month | -9.07% |
| 3 months | -9.86% |
| Year-to-date | -73.13% |
| 1 year | -87.19% |
| 3 years | -95.60% |
| 5 years | -99.86% |
52-Week Range
| 52-week High | $2.92 |
| 52-week Low | $0.28 |
| Avg Volume (90d) | 5.0M |
Technical Indicators
| SMA 50 | $0.38 |
| SMA 200 | $0.86 |
| Beta | 1.94 |
| 30-day Volatility (annualised) | 40.7% |
| Price vs SMA 50 | -4.1% |
| Price vs SMA 200 | -58.2% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $1.55 | |
| 2025-11 | $1.59 | +2.6% |
| 2025-12 | $1.34 | -15.7% |
| 2026-01 | $1.25 | -6.7% |
| 2026-02 | $1.18 | -5.6% |
| 2026-03 | $1.18 | +0.0% |
| 2026-04 | $0.34 | -70.8% |
| 2026-05 | $0.91 | +163.8% |
| 2026-06 | $0.40 | -56.5% |
| 2026-07 | $0.37 | -5.6% |
| 2026-08 | $0.38 | +1.6% |
| 2026-09 | $0.36 | -5.2% |
Price
| Price | $0.36 |
| Market Cap | $5M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.86 |
| EV / EBITDA | 0.36 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.05 |
| Current Ratio | 2.77 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -39.65 |